Immunomodulating therapy of rheumatoid arthritis by high-dose intravenous immunoglobulin
β Scribed by Becker, H. ;Mitropoulou, G. ;Helmke, K.
- Publisher
- Springer-Verlag
- Year
- 1989
- Tongue
- English
- Weight
- 579 KB
- Volume
- 67
- Category
- Article
- ISSN
- 1432-1440
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
Treatment with high-dose (400 mg/kg/ day) intravenous immunoglobulin ( M g ) shows benefit in many autoimmune diseases but is very expensive. Low-dose M g has also been shown to be effective in inhibiting adjuvant arthritis in the rat. This pilot, randomized, double-blind, placebo-controlled trial w
Induction therapy with an intravenous loading dose of azathioprine for treatment of refractory
ITP in pregnancy may lead to fetal thrombocytopenia caused by the transplacental passage of maternal antiplatelet antibody. The most hazardous complication in the infant is intracranial hemorrhage. In addition ITP in pregnancy is reported to be associated with an increased abortion rate and an eleva